INTERMOLECULAR INC
Technology · Semiconductors & Related Devices · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | |
|---|---|---|---|---|---|---|
| Revenue | $33.7M | $37.2M | $47.3M | $45.3M | $47.7M | $67.4M |
| Operating income | −$4.3M | −$11.0M | −$15.9M | −$20.7M | −$21.0M | −$8.0M |
| Net income | −$3.4M | −$10.4M | −$15.4M | −$21.0M | −$21.8M | −$8.8M |
| Total assets | $43.4M | $44.3M | $53.2M | $69.7M | $105.4M | $124.5M |
| Total liabilities | $9.0M | $8.2M | $8.2M | $13.6M | $35.2M | $39.6M |
| Equity | $34.4M | $36.1M | $45.0M | $56.1M | $70.3M | $84.9M |
| EPS (diluted) | — | — | — | — | — | — |
| Shares out. | 49.6M | 49.5M | 49.5M | 48.4M | 46.8M | 44.4M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2018- Operating margin
- −12.9%
- Net margin
- −10.1%
- Return on equity
- −9.9%
- Return on assets
- −7.9%
- Return on capital (ROCE)
- −11.7%
- Liabilities / assets
- 20.8%
- Debt / equity
- 0.26×
- Book value / share
- $0.69
- Revenue growth (YoY)
- −9.5%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2018- Altman Z″ (distress)
- -6.02distress
- Accruals / assets
- −21.5%clean
- Beneish M-Score
- -4.05normal
- Piotroski F-Score
- 4/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 3 warning● 3 good- Altman Z″ in the distress zone
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsSep 20, 2019
- Results of operationsAug 8, 2019
- Shareholder vote · Other material eventJul 17, 2019
- Results of operationsMay 14, 2019
- Entered a material agreement · Other material eventMay 6, 2019
- Results of operationsFeb 12, 2019
- Delisting / listing-standard noticeDec 28, 2018
- Results of operations · Other material eventNov 6, 2018
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 15-12BFORM 15-12BSep 30, 2019
- 4OWNERSHIP DOCUMENTSep 24, 2019
- SC 13D/AAMENDMENT NO. 9 TO SCHEDULE 13DSep 24, 2019
- S-8 POSSep 23, 2019
- S-8 POSSep 23, 2019
- S-8 POSSep 23, 2019
- S-8 POSSep 23, 2019
- S-8 POSSep 23, 2019
- S-8 POSSep 23, 2019
- S-8 POSSep 23, 2019
- S-8 POSSep 23, 2019
- S-8 POSSep 23, 2019
- 4FORM 4Sep 20, 2019
- 4FORM 4Sep 20, 2019
- 4FORM 4Sep 20, 2019